ZEBRAFISH MODEL FOR MELANOMA
Our lab recently transitioned to using
zebrafish as a model for the investigating the early events leading to
melanoma. I learned the advantages of
using zebrafish while I was a US Fulbright Research Fellow in Ireland (Jan-July 2008) at
the Dublin Institute of Technology’s Facility for
Optical Characterization and Spectroscopy (FOCAS). During this time I worked with the
Radiation and Environmental Science group on the cellular and subcellular
responses to UVA radiation. While there
I became acquainted with several labs in Ireland who were using zebrafish for
research. I was very much impressed with how zebrafish
could help me answer important questions about how melanocyte stem cells might
be involved in UV-induced melanoma.
INSTALLATION
OF ZEBRAFISH HABITAT
After
returning to campus, I received a Faculty Merit Award to purchase a
continuously cycling Aquaneering System to
start a zebrafish research colony. This
is now located in the Animal Care Facility in the Science Building at Ferris
State University. Each tank is a
baffle/tank system that ebbs water in a circular motion to ensure flushing and
water turnover. Ultraviolet (UV) sterilizers (110,000 microwatt-s cm−2)
are used to disinfect the water and prevent the spread of disease in the
re-circulating system. The water temperature is maintained at 28±0.5°C. The
system continuously circulates water from the tanks through Siporax™ strainers,
through a fiber mechanical filtration system, and finally into a chamber
containing foam filters and activated carbon inserts. Zebrafish are maintained
with a 14:10 h light/dark cycle and fed living brine shrimp twice per day.

Ryan Freye (standing
left) is now in pharmacy school. He was
instrumental in beginning stages of our research program to document all the
procedures for zebrafish breeding and rearing, and took a major role in
performing and documenting the fish radiation protocols. Richard Marble (standing right), Director of
the Animal Care Facility, has overall responsibility for the management of the
zebrafish colony. Jim Hoerter (seated)
is P.I. for the project.
Shortly after
returning to Ferris State University, O’Reilly-Pol and Johnson’s paper was published
demonstrating how neocuproine can be used to control the differentiation of
melanocytes from melanocyte adult stem cells.
This technique provides a powerful method to determine if UVA in
sunlight can damage melanocyte stem cells and contribute to the development of
melanoma. Although human epidermal melanocyte stem cells have not been
definitely isolated, they are likely to exist based on the presence of stem
cell markers on cells located on the basal layer of the epidermis. Zebrafish is the only animal model thus far
that permits the elimination of adult melanocytes without affecting their ability to regenerate them from adult
melanocyte stem.
I
recently received an NIH
Academic Research Enhancement Award ($347,000) to investigate the effects
of UVA/UVB irradiation on melanocyte stem cells. My research will help to determine if the
cellular origin of melanoma is the melanocyte stem cell.
UVA/UVB RADIATION AND MELANOMA
The role that UVA (320-400 nm) and UVB
(290-320 nm) radiation plays in the development of melanoma is not clear. UVA radiation, which is more penetrating than
UVB, may cause the accumulation of mutations in melanocyte stem cells,
contributing to the development of melanoma when these stem cells divide to
replace damaged adult melanocytes in the basal layer of the epidermis.
Hopefully, our studies will provide insights as to how sunlight UVA and UVB
might be contributing to the development of melanoma.
Exposure to
ultraviolet light is an important causative factor in melanoma, although the
relationship between risk and exposure is complex. Intermittent sun exposure and sunburn history
are important variables in the development of melanoma (1).
It is controversial as to whether the UVB (290-320 nm) or the UVA
(320-400 nm) wavelengths of solar radiation is more important in melanoma
development (2,3). But epidemiological evidence suggests that
both UVA and UVB are involved in melanoma causation (4,5). It is still unclear how a normal melanocyte
becomes a melanoma cell, and how the properties of the normal melanocyte and/or
its progenitors are utilized in its transformation. Determining the etiology of melanoma and the
mechanisms involved in melanoma genesis are required for the development of
more effective early detection and prevention and treatment strategies.
UVA
(320-400 nm) plays a much more important role in melanoma than previous thought
(6). More than
20% of UVA reaches the basal layers of the skin compared to less than 10% for
UVB (7).
Thus, much more UVA is able to penetrate down to the basal layer of the
epidermis where the stem cells reside and may play an important role in the
early stages of transformation (7,8). Absorption of UVA leads to the production of
reactive oxygen and nitrogen species that can damage major biomolecules
including DNA and membrane lipids.
Various types of damage induced in these molecules lead to significant
biological effects including cytotoxicity, mutations and alternations in cell
signaling pathways (9).
Longer-term effects such as persistent genomic instability and bystander
effects have also been observed following UVA treatment of mammalian cells (10-12).
RESEARCH
OBJECTIVES
Melanoma is the most deadly form of
human skin cancer. Over the past several
decades, the incidence of melanoma has steadily risen in the United States with
about 60,000 cases and 8,000 deaths reported each year. Although solar UVB radiation plays a leading
role in melanoma, it is still not clear where the damage actually
originates. The long-standing
hypothesis is that mature melanocytes accumulate mutations over time until
critical genes are damaged and the melanocyte is transformed. My research plan
will investigate an alternative hypothesis that solar radiation damages
melanocyte stem cells, recently discovered in the myelin sheath of nerves
innervating the skin.
The long-range goal of my undergraduate research lab is to identify the
early molecular events responsible for the development of melanoma. The primary
objective of this research project is to test the hypothesis that melanoma
is initiated in the melanocyte stem cell after exposure to solar UVB/UVA
irradiation. This research plan has the
following specific aims: (1)
determine if UVB/UVA irradiation of melanocyte stem cells with activated human
BRAF and NRAS oncogenes will increase the incidence of melanocytic tumors (2) determine if additional
UVB/UVA irradiation of the regenerated
adult melanocytes derived from these previously
irradiated stem cells will increase the number of melanocytic tumors, (3)
determine if a melanocyte in early stages of differentiation is more
susceptible to UVB/UVA-induced transformation than one in later stages of
differentiation, (4) determine if
the tumor suppressor p53 affects UVB/UVA damage/repair of melanocyte stem cells, and (5) determine if cellular senescence,
known to be a powerful tumor-suppressive process that prevents excessive
proliferation, is suppressed by UVB/UVA irradiation of either melanocyte stem
cells or adult melanocytes. We will take advantage of the zebrafish
melanoma model. Zebrafish genes
controlling melanocyte development and differentiation are highly conserved and
very similar to mammals. The unique
advantage of the zebrafish model system is that it permits synchronization and
control of melanocyte regeneration, permitting us to selectively irradiate the
entire melanocyte stem population at once and/or the entire adult melanocyte
population at the same stage of differentiation. This synchronization cannot be
achieved in mammalian systems.
Our working
hypothesis is that melanocyte stem cells accumulate UVB/UVA-induced
mutations over time due to defects in repair pathways. Later in life when adult melanocytes are
regenerated from these stem cells they will carry a mutational load and will be
more susceptible to UVB/UVA-induced transformation. Melanocytes exposed to UVB/UVA at different
stages differentiation will give forth different melanocytic lesions ranging
from invasive malignant melanoma to isolated atypical epidermal melanocytes or
nevi. The experimental plan will utilize a recently reported method for
ablating adult melanocytes but not melanocyte stem cells, permitting us to
irradiate only the melanocyte stem cell population and then observing how this
affects regenerated melanocytes derived from these stem cells. The entire melanocyte population is
regenerated simultaneously within 4 weeks after drug washout, permitting us to
irradiate at different stages of differentiation by simply changing the time of
irradiation. We will utilize transgenic
human BRAF and NRAS activated oncogenes, as well as a p53 mutant under control
of a melanocyte promoter to accelerate the development of tumors.

We
expose zebrafish to UVA and UVB using a circular radiation chamber. Zebrafish
are kept in the dark to prevent following treatment to photoreactivation
repair. All zebrafish experiments are performed in accordance to regulatory
standards as accepted by the Institutional Animal Care and Use Committee
(IACUC) at Ferris State University. This
animal care facility is accredited by AAALAC which
validates the institution's commitment to the highest standard of animal care
and use recognized in this country.
RESEARCH ASSISTANTS
Patrick Bradley, Lab Manager.
Alexandria
Casillas, NIH Post-Baccalaureate Fellow.
Rebecca Finder, Zebrafish Habitat Director
Danielle Chambers, Research Assistant
Kimberly Johnson, Research Assistant
Carli Denholm, Research Assistant
Brandon Weiswasser, Research Assistant
Lauren Clements, Research
Assistant
Sarah Gilbert, Research
Assistant
Katey Williams and Albert
Jiao, Math/Science
Center High School
REFERENCES
1. Gandini,
S., F. Sera, M. S. Cattaruzza, P. Pasquini, O. Picconi, P. Boyle, and C. F.
Melchi (2005) Meta-analysis of risk factors for cutaneous melanoma: II. Sun
exposure. Eur. J. Cancer 41, 45-60.
2. Wang,
S. Q., R. Setlow, M. Berwick, D. Polsky, A. A. Marghoob, A. W. Kopf, and R. S.
Bart (2001) Ultraviolet A and melanoma: a review. J. Am. Acad. Dermatol. 44, 837-846.
3. De
Fabo, E. C., F. P. Noonan, T. Fears, and G. Merlino (2004) Ultraviolet B but
not ultraviolet A radiation initiates melanoma. Cancer Res. 64, 6372-6376.
4. Oliveria,
S., S. Dusza, and M. Berwick (2001) Issues in the epidemiology of melanoma. Expert. Rev. Anticancer Ther. 1,
453-459.
5. Garland,
C. F., F. C. Garland, and E. D. Gorham (2003) Epidemiologic evidence for
different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann. Epidemiol. 13, 395-404.
6. Wang,
L. E., P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F.
Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, M. Duvic, G. L.
Clayman, R. S. Weber, S. M. Lippman, C. I. Amos, M. R. Spitz, and Q. Wei (2005)
In vitro sensitivity to ultraviolet B light and skin cancer risk: a
case-control analysis. J. Natl. Cancer
Inst. 97, 1822-1831.
7. Bruls,
W. A., H. Slaper, J. C. van der Leun, and L. Berrens (1984) Transmission of
human epidermis and stratum corneum as a function of thickness in the
ultraviolet and visible wavelengths. Photochem.
Photobiol. 40, 485-494.
8. Bruls,
W. A., W. H. van, and J. C. van der Leun (1984) Transmission of UV-radiation
through human epidermal layers as a factor influencing the minimal erythema
dose. Photochem. Photobiol. 39,
63-67.
9. McMillan,
T. J., E. Leatherman, A. Ridley, J. Shorrocks, S. E. Tobi, and J. R. Whiteside
(2008) Cellular effects of long wavelength UV light (UVA) in mammalian cells. J. Pharm. Pharmacol. 60, 969-976.
10. Dahle,
J., E. ngell-Petersen, H. B. Steen, and J. Moan (2001) Bystander effects in
cell death induced by photodynamic treatment UVA radiation and inhibitors of
ATP synthesis. Photochem. Photobiol.
73, 378-387.
11. Dahle,
J. and E. Kvam (2003) Induction of delayed mutations and chromosomal
instability in fibroblasts after UVA-, UVB-, and X-radiation. Cancer Res. 63, 1464-1469.
12. Dahle,
J., E. Kvam, and T. Stokke (2005) Bystander effects in UV-induced genomic
instability: antioxidants inhibit delayed mutagenesis induced by ultraviolet A
and B radiation. J. Carcinog. 4, 11.